Research LetterIn-Press PreviewCell biologyOncology
Open Access | 
10.1172/jci.insight.209426
ROCK2 inhibitor belumosudil overcomes resistance to KRAS inhibition in pancreatic cancer models
Alejandra M. Marinelarena,1 Thao D. Pham,1 Jeffrey H. Becker,1 Apurba Majumder,1 and Hidayatullah G. Munshi1
1Division of Hematology-Oncology, Feinberg School of Medicine, Northwestern University, Chicago, United States of America
Find articles by Marinelarena, A. in: PubMed | Google Scholar
1Division of Hematology-Oncology, Feinberg School of Medicine, Northwestern University, Chicago, United States of America
Find articles by
Pham, T.
in:
PubMed
|
Google Scholar
|
1Division of Hematology-Oncology, Feinberg School of Medicine, Northwestern University, Chicago, United States of America
Find articles by Becker, J. in: PubMed | Google Scholar
1Division of Hematology-Oncology, Feinberg School of Medicine, Northwestern University, Chicago, United States of America
Find articles by Majumder, A. in: PubMed | Google Scholar
1Division of Hematology-Oncology, Feinberg School of Medicine, Northwestern University, Chicago, United States of America
Find articles by
Munshi, H.
in:
PubMed
|
Google Scholar
|
Published November 3, 2026 - More info
Copyright © 2026, Marinelarena et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
